dacarbazine has been researched along with Adenofibroma in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Beal, DD; Bryan, GT; Cohen, SM; Croft, WA; Skibba, JL | 1 |
1 other study(ies) available for dacarbazine and Adenofibroma
Article | Year |
---|---|
Carcinogenicity of the antineoplastic agent, 5-(3,3-dimethyl-1-triazeno)-imidazole-4-carboxamide, and its metabolites in rats.
Topics: Adenofibroma; Administration, Oral; Animals; Aza Compounds; Carcinogens; Dacarbazine; Dose-Response Relationship, Drug; Ependymoma; Female; Hypoxanthines; Injections, Intraperitoneal; Intubation, Gastrointestinal; Leiomyosarcoma; Male; Mammary Neoplasms, Experimental; Neoplasms, Experimental; Organ Specificity; Rats; Stomach Neoplasms; Thymus Neoplasms; Time Factors; Triazenes; Urinary Bladder Neoplasms; Uterine Neoplasms | 1975 |